{"id":"https://openalex.org/W2215478602","doi":"https://doi.org/10.1002/jcc.24281","title":"A mixed DFT-MD methodology for thein silicodevelopment of drug releasing macrocycles. Calix and thia-calix[N]arenes as carriers for Bosutinib and Sorafenib","display_name":"A mixed DFT-MD methodology for thein silicodevelopment of drug releasing macrocycles. Calix and thia-calix[N]arenes as carriers for Bosutinib and Sorafenib","publication_year":2015,"publication_date":"2015-12-29","ids":{"openalex":"https://openalex.org/W2215478602","doi":"https://doi.org/10.1002/jcc.24281","mag":"2215478602","pmid":"https://pubmed.ncbi.nlm.nih.gov/26714797"},"language":"en","primary_location":{"is_oa":false,"landing_page_url":"https://doi.org/10.1002/jcc.24281","pdf_url":null,"source":{"id":"https://openalex.org/S21117631","display_name":"Journal of Computational Chemistry","issn_l":"0192-8651","issn":["0192-8651","1096-987X"],"is_oa":false,"is_in_doaj":false,"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"version":null,"is_accepted":false,"is_published":false},"type":"article","type_crossref":"journal-article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048313513","display_name":"Rodrigo Galindo\u2010Murillo","orcid":"https://orcid.org/0000-0001-5847-4143"},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165","https://openalex.org/I2801365484"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rodrigo Galindo-Murillo","raw_affiliation_string":"Department of Medicinal Chemistry, College of Pharmacy, University of Utah, Salt Lake City, Utah, 84112","raw_affiliation_strings":["Department of Medicinal Chemistry, College of Pharmacy, University of Utah, Salt Lake City, Utah, 84112"]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005012111","display_name":"Luis Enrique Aguilar-Su\u00e1rez","orcid":null},"institutions":[{"id":"https://openalex.org/I179647637","display_name":"Universidad Aut\u00f3noma del Estado de M\u00e9xico","ror":"https://ror.org/0079gpv38","country_code":"MX","type":"education","lineage":["https://openalex.org/I179647637"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"Luis Enrique Aguilar-Su\u00e1rez","raw_affiliation_string":"Centro Conjunto De Investigaci\u00f3n En Qu\u00edmica Sustentable UAEM\u2010UNAM Toluca Estado De M\u00e9xico 50200 Mexico","raw_affiliation_strings":["Centro Conjunto De Investigaci\u00f3n En Qu\u00edmica Sustentable UAEM\u2010UNAM Toluca Estado De M\u00e9xico 50200 Mexico"]},{"author_position":"last","author":{"id":"https://openalex.org/A5088106333","display_name":"Joaqu\u0131\u0301n Barroso-Flores","orcid":"https://orcid.org/0000-0003-0554-7569"},"institutions":[{"id":"https://openalex.org/I179647637","display_name":"Universidad Aut\u00f3noma del Estado de M\u00e9xico","ror":"https://ror.org/0079gpv38","country_code":"MX","type":"education","lineage":["https://openalex.org/I179647637"]}],"countries":["MX"],"is_corresponding":true,"raw_author_name":"Joaqu\u00edn Barroso-Flores","raw_affiliation_string":"Centro Conjunto De Investigaci\u00f3n En Qu\u00edmica Sustentable UAEM\u2010UNAM Toluca Estado De M\u00e9xico 50200 Mexico","raw_affiliation_strings":["Centro Conjunto De Investigaci\u00f3n En Qu\u00edmica Sustentable UAEM\u2010UNAM Toluca Estado De M\u00e9xico 50200 Mexico"]}],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5088106333"],"corresponding_institution_ids":["https://openalex.org/I179647637"],"apc_list":{"value":4840,"currency":"USD","value_usd":4840,"provenance":"doaj"},"apc_paid":{"value":4840,"currency":"USD","value_usd":4840,"provenance":"doaj"},"has_fulltext":true,"fulltext_origin":"ngrams","cited_by_count":8,"cited_by_percentile_year":{"min":87,"max":88},"biblio":{"volume":"37","issue":"10","first_page":"940","last_page":"946"},"is_retracted":false,"is_paratext":false,"primary_topic":{"id":"https://openalex.org/T10163","display_name":"Platinum-Based Cancer Chemotherapy","score":0.9986,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10163","display_name":"Platinum-Based Cancer Chemotherapy","score":0.9986,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10044","display_name":"Protein Structure Prediction and Analysis","score":0.9976,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Recent Advances in Triazine Chemistry","score":0.9975,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"keyword":"drug releasing macrocycles","score":0.6577},{"keyword":"thein silicodevelopment","score":0.3095},{"keyword":"bosutinib","score":0.2648},{"keyword":"thia-calix[n]arenes","score":0.25}],"concepts":[{"id":"https://openalex.org/C2778208673","wikidata":"https://www.wikidata.org/wiki/Q894611","display_name":"Bosutinib","level":5,"score":0.7508635},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6965333},{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.68531406},{"id":"https://openalex.org/C2775905019","wikidata":"https://www.wikidata.org/wiki/Q192572","display_name":"In silico","level":3,"score":0.57381463},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.5413319},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.47170115},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.38330287},{"id":"https://openalex.org/C147597530","wikidata":"https://www.wikidata.org/wiki/Q369472","display_name":"Computational chemistry","level":1,"score":0.32617646},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.25642774},{"id":"https://openalex.org/C2777413986","wikidata":"https://www.wikidata.org/wiki/Q412327","display_name":"Nilotinib","level":4,"score":0.20528},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.13719937},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.0},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.0},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000814","descriptor_name":"Aniline Compounds","qualifier_ui":"","qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D047250","descriptor_name":"Calixarenes","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D003198","descriptor_name":"Computer Simulation","qualifier_ui":"","qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004337","descriptor_name":"Drug Carriers","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D065546","descriptor_name":"Drug Liberation","qualifier_ui":"","qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D056004","descriptor_name":"Molecular Dynamics Simulation","qualifier_ui":"","qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009536","descriptor_name":"Niacinamide","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":"","qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D010671","descriptor_name":"Phenylurea Compounds","qualifier_ui":"","qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011789","descriptor_name":"Quantum Theory","qualifier_ui":"","qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"","qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D047250","descriptor_name":"Calixarenes","qualifier_ui":"","qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004337","descriptor_name":"Drug Carriers","qualifier_ui":"","qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":"","qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009536","descriptor_name":"Niacinamide","qualifier_ui":"","qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077157","descriptor_name":"Sorafenib","qualifier_ui":"","qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"is_oa":false,"landing_page_url":"https://doi.org/10.1002/jcc.24281","pdf_url":null,"source":{"id":"https://openalex.org/S21117631","display_name":"Journal of Computational Chemistry","issn_l":"0192-8651","issn":["0192-8651","1096-987X"],"is_oa":false,"is_in_doaj":false,"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"version":null,"is_accepted":false,"is_published":false},{"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26714797","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":["National Institutes of Health"],"type":"repository"},"license":null,"version":null,"is_accepted":false,"is_published":false}],"best_oa_location":null,"sustainable_development_goals":[],"grants":[],"referenced_works_count":31,"referenced_works":["https://openalex.org/W1592246595","https://openalex.org/W1968984443","https://openalex.org/W1969135955","https://openalex.org/W1976499671","https://openalex.org/W1976548990","https://openalex.org/W1991388211","https://openalex.org/W1994538662","https://openalex.org/W2001921621","https://openalex.org/W2004822259","https://openalex.org/W2009882040","https://openalex.org/W2018478612","https://openalex.org/W2019782687","https://openalex.org/W2027364606","https://openalex.org/W2035350110","https://openalex.org/W2060464523","https://openalex.org/W2070003597","https://openalex.org/W2080586621","https://openalex.org/W2083164919","https://openalex.org/W2090551671","https://openalex.org/W2093381148","https://openalex.org/W2106140689","https://openalex.org/W2140133298","https://openalex.org/W2147993766","https://openalex.org/W2150681295","https://openalex.org/W2167029191","https://openalex.org/W2313116527","https://openalex.org/W2316928488","https://openalex.org/W2323371369","https://openalex.org/W2332712348","https://openalex.org/W2332974528","https://openalex.org/W4251403035"],"related_works":["https://openalex.org/W2415520711","https://openalex.org/W3014741021","https://openalex.org/W2256992551","https://openalex.org/W3118995675","https://openalex.org/W2342123427","https://openalex.org/W2083715308","https://openalex.org/W2042461252","https://openalex.org/W2523716991","https://openalex.org/W2333911119","https://openalex.org/W2339564172"],"ngrams_url":"https://api.openalex.org/works/W2215478602/ngrams","abstract_inverted_index":{"Interaction":[0],"energies":[1],"between":[2],"a":[3],"family":[4],"of":[5,39,51,95],"36":[6],"calix[":[7],"n":[8],"]arenes,":[9],"their":[10,63,68],"corresponding":[11],"thia":[12],"\u2010":[13],"analogues,":[14],"and":[15,25,65,118,134],"two":[16],"commercially":[17],"available":[18],"second":[19],"generation":[20],"tyrosine":[21],"kinase":[22],"III":[23],"inhibitors\u2014Bosutinib":[24],"Sorafenib\u2014were":[26],"calculated":[27],"through":[28],"DFT":[29],"methods":[30],"at":[31],"the":[32,47,57,79,92,123,143],"B97D/6\u201031G(":[33],"d":[34],",":[35],"p":[36],")":[37],"level":[38],"theory,":[40],"based":[41,55],"on":[42,56],"Natural":[43],"Population":[44],"Analysis,":[45],"for":[46,126,146],"in":[48,66,88,98],"silico":[49],"development":[50],"suitable":[52],"drug":[53],"carriers":[54],"aforementioned":[58],"macrocycles":[59],"which":[60],"can":[61],"increase":[62],"bioavailability":[64],"turn":[67],"pharmaceutical":[69],"efficiency.":[70],"Molecular":[71],"Dynamics":[72],"simulations":[73],"(production":[74],"runs:":[75],"+500":[76],"ns)":[77],"using":[78],"General":[80],"Amber":[81],"Force":[82],"Field":[83],"were":[84],"also":[85],"carried":[86],"out":[87],"order":[89],"to":[90,111],"assess":[91],"releasing":[93],"process":[94],"these":[96],"drugs":[97],"an":[99],"explicit":[100],"aqueous":[101],"environment.":[102],"In":[103],"total,":[104],"144":[105],"host\u2013guest":[106],"complexes":[107],"are":[108,122,142],"examined.":[109],"According":[110],"our":[112],"results,":[113],"five\u2010membered":[114],"\uf8ffSO":[115,131],"3":[116,132],"H":[117,133,137],"i":[119],"\u2013Pr":[120],"functionalized\u2010calixarenes":[121],"best":[124],"candidates":[125,145],"Sorafenib\u2010carriers":[127],"while":[128],"six\u2010membered":[129],"ones":[130],"C":[135],"2":[136,140],"4":[138],"NH":[139],"functionalized\u2013":[141],"lead":[144],"Bosutinib\u2010carriers.":[147],"\u00a9":[148],"2015":[149],"Wiley":[150],"Periodicals,":[151],"Inc.":[152]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2215478602","counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3}],"updated_date":"2024-03-27T09:35:29.924746","created_date":"2016-06-24"}